Dare Bioscience, Inc. Restricted Cash and Cash Equivalents, Noncurrent
Dare Bioscience, Inc. (DARE) had Restricted Cash and Cash Equivalents, Noncurrent of $300.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2026-08-13
- 2026-06-30: Restricted Cash and Cash Equivalents, Noncurrent $300.00K.
- 2026-03-31: Restricted Cash and Cash Equivalents, Noncurrent $300.00K.
- 2025-12-31: Restricted Cash and Cash Equivalents, Noncurrent $300.00K.
- 2025-09-30: Restricted Cash and Cash Equivalents, Noncurrent $300.00K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2026-06-30 | $300.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $300.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $300.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $300.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $300.00K 10-Q · filed 2026-08-13 |
| 2025-03-31 | $300.00K 10-Q · filed 2026-05-14 |
| 2024-12-31 | $300.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $300.00K 10-Q · filed 2025-11-13 |
| 2024-06-30 | $300.00K 10-Q · filed 2025-08-14 |
| 2024-03-31 | $335.00K 10-Q · filed 2025-05-13 |
| 2023-12-31 | $335.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $335.00K 10-Q · filed 2024-11-14 |
| 2023-06-30 | $335.00K 10-Q · filed 2024-08-12 |
| 2023-03-31 | $85.00K 10-Q · filed 2024-05-14 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-10 |
| 2016-12-31 | $230.00K 10-K/A · filed 2017-06-13 |
| 2015-12-31 | $347.00K 10-K/A · filed 2017-06-13 |
| 2014-12-31 | $117.00K 10-K · filed 2016-03-10 |
| 2013-12-31 | $117.00K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |